112 related articles for article (PubMed ID: 8913843)
1. Phase II study of elsamitrucin (BMY-28090) for the treatment of patients with refractory/relapsed non-Hodgkin's lymphoma.
Allen SL; Schacter LP; Lichtman SM; Bukowski R; Fusco D; Hensley M; O'Dwyer P; Mittelman A; Rosenbloom B; Huybensz S
Invest New Drugs; 1996; 14(2):213-7. PubMed ID: 8913843
[TBL] [Abstract][Full Text] [Related]
2. Phase II study of elsamitrucin in non-small cell lung cancer.
Goss G; Letendre F; Stewart D; Shepherd F; Schacter L; Hoogendoorn P; Eisenhauer E
Invest New Drugs; 1994; 12(4):315-7. PubMed ID: 7775132
[TBL] [Abstract][Full Text] [Related]
3. Phase II studies of Elsamitrucin in breast cancer, colorectal cancer, non-small cell lung cancer and ovarian cancer. EORTC Early Clinical Trials Group.
Verweij J; Wanders J; Nielsen AL; Pavlidis N; Calabresi F; ten Bokkel Huinink W; Bruntsch U; Piccart M; Franklin H; Kaye SB
Ann Oncol; 1994 Apr; 5(4):375-6. PubMed ID: 8075039
[TBL] [Abstract][Full Text] [Related]
4. Phase II trial of docetaxel in non-Hodgkin's lymphomas: a study of the Cancer and Leukemia Group B.
Budman DR; Petroni GR; Johnson JL; Cooper MR; Schlossman DM; Barcos M; Peterson BA
J Clin Oncol; 1997 Oct; 15(10):3275-9. PubMed ID: 9336365
[TBL] [Abstract][Full Text] [Related]
5. An open-label, dose-escalating phase I study of elsamitrucin (SPI 28090) in treatment of malignant solid tumors in dogs.
Fiocchi SC; Selting KA; Rosenberg MP; Kolli P; Lenaz G; Henry C
J Vet Intern Med; 2011; 25(4):897-902. PubMed ID: 21736623
[TBL] [Abstract][Full Text] [Related]
6. Phase I trial and clinical pharmacology of elsamitrucin.
Raber MN; Newman RA; Newman BM; Gaver RC; Schacter LP
Cancer Res; 1992 Mar; 52(6):1406-10. PubMed ID: 1540949
[TBL] [Abstract][Full Text] [Related]
7. Liposomal daunorubicin in the treatment of relapsed or refractory non-Hodgkin's lymphoma.
Tulpule A; Rarick MU; Kolitz J; Bernstein J; Myers A; Buchanan LA; Espina BM; Traynor A; Letzer J; Justice GR; McDonald D; Roberts L; Boswell W; Nathwani B; Levine AM
Ann Oncol; 2001 Apr; 12(4):457-62. PubMed ID: 11398876
[TBL] [Abstract][Full Text] [Related]
8. Irinotecan in relapsed or refractory non-Hodgkin's lymphoma.
Sarris AH; Romaguera J; Hagemeister FB; Rodriguez MA; McLaughlin P; Pro B; Younes A; Mesina O; Cabanillas F; Medeiros LJ; Samuels B
Oncology (Williston Park); 2001 Jul; 15(7 Suppl 8):53-6. PubMed ID: 11497233
[TBL] [Abstract][Full Text] [Related]
9. Phase II study of weekly low-dose paclitaxel for relapsed and refractory non-Hodgkin's lymphoma: a Wisconsin Oncology Network Study.
Kahl BS; Bailey HH; Smith EP; Turman N; Smith J; Werndli J; Williams EC; Longo WL; Kim KM; McGovern J; Jumonville A
Cancer Invest; 2005; 23(1):13-8. PubMed ID: 15779863
[TBL] [Abstract][Full Text] [Related]
10. [Phase II study of KRN8602 (MX2) for malignant lymphoma].
Okabe K; Sampi K; Kuraishi Y; Takemoto Y; Tamura K; Ogawa M
Gan To Kagaku Ryoho; 1998 Jun; 25(7):1001-6. PubMed ID: 9644314
[TBL] [Abstract][Full Text] [Related]
11. High-Dose celecoxib and metronomic "low-dose" cyclophosphamide is an effective and safe therapy in patients with relapsed and refractory aggressive histology non-Hodgkin's lymphoma.
Buckstein R; Kerbel RS; Shaked Y; Nayar R; Foden C; Turner R; Lee CR; Taylor D; Zhang L; Man S; Baruchel S; Stempak D; Bertolini F; Crump M
Clin Cancer Res; 2006 Sep; 12(17):5190-8. PubMed ID: 16951238
[TBL] [Abstract][Full Text] [Related]
12. [Efficacy of rituximab-containing salvage regimens on relapsed or refractory B-cell non-Hodgkin's lymphoma].
Huang HQ; Bu Q; Xia ZJ; Lin XB; Wang FH; Li YH; Peng YL; Pan ZH; Wang SS; Lin TY; Jiang WQ; Guan ZZ
Ai Zheng; 2006 Apr; 25(4):486-9. PubMed ID: 16613686
[TBL] [Abstract][Full Text] [Related]
13. Phase II trial of menogaril in non-Hodgkin's lymphomas: a Southwest Oncology Group trial.
Moore DF; Brown TD; LeBlanc M; Dahlberg S; Miller TP; McClure S; Fisher RI
Invest New Drugs; 1999; 17(2):169-72. PubMed ID: 10638487
[TBL] [Abstract][Full Text] [Related]
14. Paclitaxel plus topotecan treatment for patients with relapsed or refractory aggressive non-Hodgkin's lymphoma.
Younes A; Preti HA; Hagemeister FB; McLaughlin P; Romaguera JE; Rodriguez MA; Samuels BI; Palmer JL; Cabanillas F
Ann Oncol; 2001 Jul; 12(7):923-7. PubMed ID: 11521796
[TBL] [Abstract][Full Text] [Related]
15. An oxaliplatin-based chemotherapy in patients with relapsed or refractory intermediate and high-grade non-Hodgkin's lymphoma.
Chau I; Webb A; Cunningham D; Hill M; Rao S; Ageli S; Norman A; Gill K; Howard A; Catovsky D
Br J Haematol; 2001 Dec; 115(4):786-92. PubMed ID: 11843810
[TBL] [Abstract][Full Text] [Related]
16. [A phase II study of mitoxantrone in refractory and relapsed malignant lymphomas. Cooperative Study Group of Mitoxantrone in Malignant Lymphomas].
Kimura I; Ohnoshi T; Ogawa M; Sampi K; Masaoka T; Yamada K; Ohta K; Kitani T; Kawagoe H; Shirakawa S
Gan To Kagaku Ryoho; 1986 Sep; 13(9):2800-6. PubMed ID: 3753026
[TBL] [Abstract][Full Text] [Related]
17. Cisplatin, fludarabine, and cytarabine: a novel, pharmacologically designed salvage therapy for patients with refractory, histologically aggressive or mantle cell non-Hodgkin's lymphoma.
Seymour JF; Grigg AP; Szer J; Fox RM
Cancer; 2002 Feb; 94(3):585-93. PubMed ID: 11857288
[TBL] [Abstract][Full Text] [Related]
18. [IEMAD (modified MIME) therapy for refractory or relapsed non-Hodgkin's lymphoma].
Li HH; Wu XX; Wang QS; Zhao Y; Bo J; Wang SH; DA WM; Yu L
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2006 Apr; 14(2):298-300. PubMed ID: 16638201
[TBL] [Abstract][Full Text] [Related]
19. A phase II study of topotecan in non-Hodgkin's lymphoma: an Ohio State University phase II research consortium study.
Kraut EH; Balcerzak SP; Young D; Davis MP; Jacobs SA;
Cancer Invest; 2002; 20(2):174-9. PubMed ID: 11901536
[TBL] [Abstract][Full Text] [Related]
20. Refractory or relapsed Hodgkin's disease and non-Hodgkin's lymphoma: optimizing involved-field radiotherapy in transplant patients.
Kahn ST; Flowers CR; Lechowicz MJ; Hollenbach K; Johnstone PA
Cancer J; 2005; 11(5):425-31. PubMed ID: 16259874
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
